Edition:
United Kingdom

Abbott Laboratories Reports Q2 Gaap Earnings Per Share $0.56 From Continuing Operations


Wednesday, 17 Jul 2019 

July 17 (Reuters) - Abbott Laboratories ::ABBOTT REPORTS SECOND-QUARTER 2019 RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $0.82 FROM CONTINUING OPERATIONS EXCLUDING ITEMS.Q2 GAAP EARNINGS PER SHARE $0.56 FROM CONTINUING OPERATIONS.Q2 EARNINGS PER SHARE ESTIMATE $0.80 -- REFINITIV IBES DATA.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $3.21 TO $3.27 FROM CONTINUING OPERATIONS.SEES Q3 ADJUSTED EARNINGS PER SHARE $0.83 TO $0.85 FROM CONTINUING OPERATIONS EXCLUDING ITEMS.SEES Q3 2019 GAAP EARNINGS PER SHARE $0.53 TO $0.55 FROM CONTINUING OPERATIONS.SEES FY 2019 GAAP EARNINGS PER SHARE $2.06 TO $2.12 FROM CONTINUING OPERATIONS.RAISING FULL-YEAR GUIDANCE FOR ORGANIC SALES GROWTH TO 7 TO 8 PERCENT.FY2019 EARNINGS PER SHARE VIEW $3.22 -- REFINITIV IBES DATA.Q3 EARNINGS PER SHARE VIEW $0.85 -- REFINITIV IBES DATA.QTRLY SALES OF $ 7,979 MILLION VERSUS $ 7,767 MILLION REPORTED LAST YEAR.RAISING FULL-YEAR EPS FORECAST.FORECASTS SPECIFIED ITEMS FOR Q3 2019 OF $0.30 PER SHARE.FORECASTS NET SPECIFIED ITEMS FOR FULL YEAR 2019 OF $1.15 PER SHARE..QTRLY PEDIATRIC SALES $1,051 MILLION, UP 0.1% ON A REPORTED BASIS.FY2019 REVENUE VIEW $31.99 BILLION -- REFINITIV IBES DATA.SAYS "OUR SALES GROWTH ACCELERATED AND IS SUSTAINABLE".QTRLY TOTAL NUTRITION SALES $1,875 MILLION, UP 0.9% ON REPORTED BASIS.QTRLY TOTAL DIAGNOSTICS SALES $1,905 MILLION, UP 1.7% ON REPORTED BASIS.Q2 REVENUE VIEW $8.00 BILLION -- REFINITIV IBES DATA.SECOND-QUARTER WORLDWIDE SALES INCREASED 7.5 PERCENT ON AN ORGANIC BASIS.